Abstract
Clinical trials are currently underway to assess the cardiovascular (CV) benefit of treating high triglycerides (TG) despite statin therapy. We evaluated the association between baseline TG levels and subsequent medical care costs among patients at high risk for CV events who had statin-controlled
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
